ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,182.96
-0.85%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,431.31
0.38%
Brent Oil
83.965
-0.44%
Bitcoin
63,704.69
-1.76%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sun BioPharma Inc (SNBP)

  7. Sun BioPharma Inc (SNBP) News

Sun BioPharma (SNBP)

Sun BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNBP
DateTimeSourceHeadlineSymbolCompany
08/10/200906:00PR Newswire (US)Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw MaterialNASDAQ:SNBP
30/09/200904:00PR Newswire (US)Sinobiopharma, Inc. Appoints New Chief Financial Officer and Director to the BoardNASDAQ:SNBP
21/09/200918:26PR Newswire (US)Emissary Capital Group Initiates Coverage on SinobiopharmaNASDAQ:SNBP
18/06/200914:30PR Newswire (US)Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its 'Tai' Drug SeriesNASDAQ:SNBP
21/05/200914:30PR Newswire (US)Sinobiopharma Applies For Two Chinese Patents For Cisatracurium BesylateNASDAQ:SNBP
20/05/200914:15PR Newswire (US)Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009NASDAQ:SNBP
14/05/200914:15PR Newswire (US)Sinobiopharma Announces 350% Increase in Production of Its Flagship Drug in the First Quarter of 2009 Over the Same Period in 20NASDAQ:SNBP
11/05/200920:49PR Newswire (US)Sinobiopharma Announces SFDA Approval of Anti-Hypertension Drug PerindoprilNASDAQ:SNBP
27/04/200921:37PR Newswire (US)Sinobiopharma Secures Rights to Seven Key PatentsNASDAQ:SNBP
24/04/200921:06PR Newswire (US)Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 200NASDAQ:SNBP
24/04/200920:30PR Newswire (US)Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009NASDAQ:SNBP
13/04/200921:00PR Newswire (US)Sinobiopharma, Inc. Signs Sales Contract for Flagship ProjectNASDAQ:SNBP
08/04/200921:26PR Newswire (US)Sinobiopharma, Inc. Appoints New Director of MarketingNASDAQ:SNBP
06/04/200921:00PR Newswire (US)Sinobiopharma Applies for Chinese Patent to Develop the Next Generation of Anti-Hypertension CompoundsNASDAQ:SNBP
03/04/200921:00PR Newswire (US)Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical SupplierNASDAQ:SNBP
24/03/200914:00PR Newswire (US)Phase IV Multi-center Clinical Study of Kutai Concludes in NanjingNASDAQ:SNBP
29/01/200916:03PR Newswire (US)Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008NASDAQ:SNBP
10/12/200820:05PR Newswire (US)Sinobiopharma Reports Highlights of Third Quarter Results for Its Operating Subsidiary, Dong Ying ChinaNASDAQ:SNBP
 Showing the most relevant articles for your search:NASDAQ:SNBP

Your Recent History

AQSE
SNOX
Sulnox
LSE
API
Abrdn Property Income
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved